Skip to main content
. 2023 Oct 24;2023(10):CD014967. doi: 10.1002/14651858.CD014967.pub2

CTRI/2020/03/023961.

Study name A randomized controlled trial of levetiracetam vs phenobarbitone for treatment of neonatal seizures
Methods RCT
Participants Neonates (35‐42 weeks) with seizures
Interventions PB 20‐30 mg/kg vs LEV 20‐30 mg
Outcomes Seizure control within 1 hour, recurrence of seizures, adverse events (respiratory depression, heart rate fluctuation, duration of hospitalisation)
Starting date 2020
Contact information manikant7@yahoo.com
Notes Estimated sample size 90, EEG not specified